I now have comprehensive information from multiple textbooks. Let me compile a thorough answer on systemic hypertension in pediatrics.
Systemic Hypertension in Pediatrics
Definition and Classification
Pediatric blood pressure is interpreted using sex, age, and height - unlike adults, a single threshold doesn't apply to children under 13.
The 2017 AAP guidelines classify BP in children as:
| Category | Age 1–12 years | Age ≥13 years |
|---|
| Normal BP | <90th percentile | <120/80 mmHg |
| Elevated BP | 90th–<95th percentile OR 120/80 to <95th percentile | 120/<80 to 129/<80 mmHg |
| Stage 1 HTN | 95th percentile to <95th + 12 mmHg or 130/80–139/89 (lower value) | 130/80–139/89 mmHg |
| Stage 2 HTN | ≥95th percentile + 12 mmHg or ≥140/90 (lower value) | ≥140/90 mmHg |
The diagnosis requires elevated BP on at least three separate occasions (except in hypertensive emergencies).
Epidemiology
- Prevalence: approximately 3.5% of children (ranges 0.3–4.5% in various studies)
- Rising due to: childhood obesity, greater salt intake, hyperlipidemia, decreased physical activity
- Higher rates in boys, adolescents, and Hispanic/African-American children in the US
- Essential hypertension is uncommon in younger children but more prevalent in adolescents
- A 2025 systematic review (PMID 40451679) confirms that childhood-to-adolescence weight trajectories are independently associated with adult hypertension
Etiology by Age Group
Secondary causes predominate in younger children; primary (essential) hypertension predominates in adolescents:
| Age Group | Common Causes |
|---|
| Newborn | Renal artery/vein thrombosis, renal stenosis, polycystic kidney disease; coarctation of the aorta; pheochromocytoma, Cushing's disease |
| Preschool (<6 yr) | Renal parenchymal/vascular disease; coarctation of the aorta; pheochromocytoma, Cushing's disease |
| School age (6–10 yr) | Endocrine: pheochromocytoma, Cushing's disease, thyrotoxicosis |
| Adolescence | Essential hypertension (especially obese); renal parenchymal disease; medications (OCPs, stimulants, steroids) |
Renovascular disease is the most common secondary cause overall. Other secondary causes include:
- Glomerulonephritis, HUS, chronic renal infections, obstructive uropathy
- Coarctation of the aorta (important to measure 4-extremity BP)
- Pheochromocytoma, Cushing's syndrome, hyperthyroidism
- Obstructive sleep apnea
- Elevated intracranial pressure (Cushing's reflex - brain attempts to maintain CPP)
- Drugs/toxins: oral contraceptives, stimulants (amphetamines), corticosteroids, NSAIDs
- Neurofibromatosis type 1
Neonates with severe hypertension frequently present with CHF as the initial finding rather than neurologic symptoms.
Clinical Features
Children may be asymptomatic or present with:
Mild symptoms:
- Headache, nausea, vomiting
- Visual changes
- Anxiety
Hypertensive crisis (severe):
- Hypertensive encephalopathy: altered consciousness, seizures, focal neurologic deficits
- Chest pain, shortness of breath from acute heart failure/pulmonary edema
- Oliguria/anuria from AKI
- In neonates and young infants: feeding problems, irritability, tachypnea, cyanosis
Key point from Miller's Anesthesia: "Acute onset of severe systemic arterial hypertension is a medical emergency with potential for cardiovascular decompensation, encephalopathy, seizures, and intracranial hemorrhage. In older children, neurologic manifestations precede cardiovascular decompensation. Neonates with severe hypertension typically present with CHF."
Hypertensive Crisis Terminology (AAP 2017)
The term "acute severe hypertension" now covers presentations previously called urgency or emergency. Key distinction remains:
| Term | Definition |
|---|
| Hypertensive urgency | Severely elevated BP without end-organ damage |
| Hypertensive emergency | BP >99th percentile + acute end-organ damage (encephalopathy, AKI, heart failure) - requires immediate treatment |
Diagnostic Evaluation
Initial workup:
- Take BP in all 4 extremities (coarctation screen)
- If elevated: repeat twice and average 3 readings
- History: maternal complications, gestational age, umbilical catheter use, dietary salt, family history
Laboratory:
- BMP (electrolytes, BUN, creatinine)
- Lipid panel
- Urinalysis (hematuria, proteinuria, casts)
- Optional: plasma renin, aldosterone, urine catecholamines (catecholamines for pheochromocytoma)
- Urine toxicology if drug use suspected
Cardiac:
- ECG and echocardiography - assess LVH or structural disease
Imaging:
- Renal Doppler ultrasound - renovascular disease, renal artery stenosis, renal vein thrombosis
Sleep study: if snoring and apneas are present
Management
Lifestyle (first-line for elevated BP and asymptomatic Stage 1 HTN):
- Diet modification (DASH-style, sodium restriction)
- Weight reduction in obese children
- Regular physical activity
- Stress reduction, adequate sleep
Pharmacologic therapy - indicated when:
- Stage 1 HTN persists despite lifestyle modifications
- Symptomatic Stage 1 HTN
- Stage 2 HTN
- Secondary hypertension requiring treatment regardless of stage
First-line drug classes:
- ACE inhibitors (e.g., captopril, enalapril)
- Angiotensin receptor blockers (ARBs)
- Calcium channel blockers (amlodipine)
- Thiazide diuretics
Long-term goal: BP <90th percentile (or <130/80 mmHg in adolescents) to reduce end-organ damage and lower adult cardiovascular risk.
Hypertensive Emergency Management:
- Immediate BP reduction by 25% in the first hour
- IV agents commonly used:
- Hydralazine (direct vasodilator): Child 0.1–0.2 mg/kg/dose IV/IM Q4–6 hr; max 20 mg/dose
- Labetalol (IV infusion)
- Nicardipine (IV infusion - preferred in many centers)
- Sodium nitroprusside (continuous infusion for most severe cases)
- Inpatient management required if: Stage 2 HTN + symptoms, or BP >30 mmHg above 95th percentile (>180/120 in adolescents)
- Consult pediatric nephrology
Target Organ Damage
End-organ effects of untreated pediatric hypertension:
- Left ventricular hypertrophy (LVH) - most common cardiac finding
- Hypertensive retinopathy
- Proteinuria and CKD progression
- Neurocognitive impairment in chronic cases
- Increased risk of adult cardiovascular disease, metabolic syndrome
Key Pediatric-Specific Points
- Always use age, sex, and height-specific percentile tables for BP interpretation in children <13 years
- The 4-extremity BP measurement is essential to exclude coarctation of the aorta
- Ambulatory blood pressure monitoring (ABPM) is preferred for confirming hypertension - it identifies white-coat hypertension and masked hypertension
- Secondary causes are far more common in young/pre-school children than in adolescents
- In neonates, ask about umbilical artery/vein catheterization (risk factor for renal artery/vein thrombosis)
- Avoid ACE inhibitors and ARBs in bilateral renal artery stenosis and in pregnancy (adolescent girls)
- Captopril must be discontinued as soon as pregnancy is detected
Sources: Rosen's Emergency Medicine (9th ed.), Tintinalli's Emergency Medicine (9th ed.), Miller's Anesthesia (10th ed.), Harriet Lane Handbook (23rd ed.), Comprehensive Clinical Nephrology (7th ed.)